|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2001)) |
IUPAC Name ![]() |
| N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 4935 | formoterol |
Synonyms ![]() |
| BD-40A |
| CGP-25827A |
| Foradil® |
| Oxeze/Oxis® |
| YM-08316 |
Database Links ![]() |
|
| CAS Registry No. | 73573-87-2 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL1256786 |
| DrugBank Ligand | DB00983 |
| PubChem CID | 3410 |
| Search Google for chemical match using the InChIKey | BPZSYCZIITTYBL-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | BPZSYCZIITTYBL |
| Search PubMed clinical trials | formoterol |
| Search PubMed titles | formoterol |
| Search PubMed titles/abstracts | formoterol |
| Wikipedia | Formoterol, Arformoterol |
| Comments |
| Formoterol is a long-acting inhalation bronchodilator. The approved drug is a racemic mixture of enantiomers; PubChem lists 6 CIDs as isotopes of this molecule. We show the non-chiral molecule here to represent the mixture. The marketed formulation may contain formoterol fumarate (PubChem CID 9912089). |